Google
Trusted Resources: News & Meetings
Latest announcements and gatherings
Veterans and AL Amyloidosis
AL Amyloidosis and Agent Orange
Veterans who develop AL amyloidosis and were exposed to Agent Orange or other herbicides during military service do not have to prove a connection between their disease and service to be eligible to receive VA health care and disability compensation.
About AL amyloidosis
AL amyloidosis is a rare disease caused when amyloid proteins are abnormally deposited in tissues or organs. Primary (AL) amyloidosis is the most common form. AL amyloidosis is not a cancer, but it can occur because of some cancers.
myBinderRelated Content
-
Troubleshooting Advice for Patients Taking Drugs for AL AmyloidosisAL amyloidosis is treated with the same ...
-
Prothena Reports Results From the Phase 3 VITAL Amyloidosis Study of NEOD001 (Birtamimab) in AL AmyloidosisProthena Corporation PLC, a clinical-sta...
-
Case Report: Treatment of Light-Chain Amyloidosis With Daratumumab Monotherapy in Two PatientsImmunoglobulin light-chain amyloidosis (...
-
Dispenzieri: AL amyloidosis treatment: focusing on venetoclax, ASCT, and IMiDs – ASG AL Webinar 2.24.24 –...https://www.youtube.com/watch?v=lzrMgtOC...
-
AL Amyloidosis: From Molecular Mechanisms to Targeted TherapiesSystemic amyloidosis is caused by misfol...
-
Chicago – Amyloidosis Support Groups Meeting – LIVE – Saturday, September 9, 2023This Meeting Is for AL Amyloidosis Only ...
-
Clarification on the Definition of Complete Haematologic Response in Light-Chain (AL) AmyloidosisThe International Society of Amyloidosis...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
